GLPwatch
Trials (2036)
Page 25 of 34.
- Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
- Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM
- A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
- Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep Apnea
- Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus
- Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
- A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide
- Fibrosis Lessens After Metabolic Surgery
- A Safety Study of LY3437943 Given as a Single Injection in Healthy Participants
- Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus
- A Study of IBI362 in Participants With Obesity or Overweight
- Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.
- Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM
- Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
- Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.
- A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients
- Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
- Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes
- Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
- DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies
- A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants
- Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity
- Incretin Microdosing for Cardiometabolic Health in People With HIV
- Comparison of Type 2 Diabetes Pharmacotherapy Regimens
- Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)
- Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.
- Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery
- Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes
- A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects
- A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes
- A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity
- The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
- EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
- Weight Loss and Physical Activity in Overweight/Obese Individuals With Knee Osteoarthritis
- A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906
- A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
- Prevent and Reverse Obesity in Children, Adolescents and Young Adults
- IDegLira HIGH Trial
- Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes
- How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea
- Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients
- Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
- A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause
- Imaging Pituitary ActiVation by Exendin
- Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function
- Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus
- Liraglutide Effect in Atrial Fibrillation
- Improved Treatment and Monitoring of Alzheimer's Disease
- A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females
- Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities
- Multiple Ascending Dose Study of AMG 598 in Adults With Obesity
- Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
- A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy.
- Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications
- The Gut Microbiome in Women With Polycystic Ovary Syndrome
- Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
- A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes